Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-456P (RNA, U6 small nuclear 456, pseudogene) refers to a **pseudogene** derived from the U6 small nuclear RNA (snRNA) gene family. The canonical U6 snRNA is a highly conserved non-coding RNA molecule essential for the functioning of the spliceosome, which catalyzes pre-mRNA splicing in eukaryotic cells[1][3]. However, as a pseudogene, RNU6-456P lacks protein-coding potential and is not known to produce a functional product. Pseudogenes may occasionally regulate gene expression through diverse RNA-mediated mechanisms or act as decoys for miRNAs or RNA-binding proteins, but most are transcriptionally silent and nonfunctional[2]. The designation "456" simply indicates a specific genomic locus or variant among the numerous U6 pseudogenes present in the human genome. These pseudogenes are not recognized as therapeutic targets (such as receptors, enzymes, or transporters) and do not have established roles in biology or disease, different from the functional U6 snRNA. In summary, RNU6-456P is an **unprocessed pseudogene** of a non-coding RNA gene without current evidence supporting its function as a biological or therapeutic target[3][2]. ### Key Points - **Not a therapeutic target:** Pseudogenes like RNU6-456P are not considered receptors, enzymes, or druggable biomolecules[2][3]. - **No direct biological function described:** Most U6 pseudogenes do not have ascribed regulatory or pathological roles, though pseudogenes in general can sometimes have indirect regulatory effects[2]. - **No known drugs, mechanisms, or biomarkers:** There are no pharmacological modulators, mechanisms of action, or known clinical biomarkers associated with RNU6-456P. - **Is_incorrect:** While the gene symbol and full name are accurate for a pseudogene, this is not a target molecule in the classical therapeutic sense and therefore is not considered a true target; also, it may be incomplete as there is limited or no functional literature. ### Notes - "RNA, U6 small nuclear 456, pseudogene" is not a misspelling, but it is an incomplete/incorrect entry as a "target" in a therapeutic or drug discovery context; it simply identifies a nonfunctional pseudogene copy of a housekeeping snRNA[2][3]. - U6 snRNA gene family members are typically represented as RNU6-XXX or RNU6PXXX in nomenclature databases, reflecting either functional or pseudogene status.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 456, pseudogene (RNU6-456P).